Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plutonium, americium, and curium are synthetic, radioactive actinide elements with significant radiological hazard. They have no known physiological function, are intensely radioactive, and pose severe health risks as environmental contaminants. Plutonium is used in nuclear fuel and weapons; americium is found in smoke detectors and as a neutron source; curium is mainly used for scientific research and power generation in space applications. Even minute exposure can cause toxicity, organ damage, and increased cancer risk due to their emission of alpha particles and long biological half-lives in the body.
No mechanism as a drug target; these elements can cause biological harm through radiotoxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plutonium, Americium, and Curium (Pu, Am, Cm).